Neurocrine Biosciences Inc NBIX 159.76 -6.29 -3.79%
Expected move
November 05, 2026 close · $160.31| Horizon | Expected move | Typical range | 2 in 3 closes | 9 in 10 closes |
|---|---|---|---|---|
| Next session | ±1.7% ±$2.73 | $157.58 – $163.04 | $157.02 – $163.60 | $154.46 – $166.16 |
| 2 sessions | ±2.4% ±$3.80 | $156.51 – $164.11 | $155.71 – $164.91 | $152.12 – $168.50 |
| 3 sessions | ±3.0% ±$4.78 | $155.53 – $165.09 | $154.60 – $166.02 | $150.13 – $170.49 |
| 1 week | ±3.8% ±$6.08 | $154.23 – $166.39 | $152.87 – $167.75 | $147.36 – $173.26 |
| 2 weeks | ±5.3% ±$8.53 | $151.78 – $168.84 | $149.76 – $170.86 | $142.11 – $178.51 |
| 3 weeks | ±6.3% ±$10.15 | $150.16 – $170.46 | $147.69 – $172.93 | $138.86 – $181.76 |
| 1 month | ±7.3% ±$11.69 | $148.62 – $172.00 | $145.72 – $174.90 | $135.54 – $185.08 |
Earnings: priced against what happened
Average implied move
±8.65%
Average actual move
9.64%
Beyond the implied move
1 / 2
| Reaction session | Implied | Actual | Used | ATM IV before → after |
|---|---|---|---|---|
| May 06, 2026 | ±8.92% | +8.86% | 0.99× | — |
| February 12, 2026 | ±8.39% | -10.43% | 1.24× | — |